TD Cowen on Summit Therapeutics plc (SMMT): 'Stat Sig Overall Survival In Akeso's HARMONi-A Bodes Well For Summit's HARMONi'
Tweet Send to a Friend
TD Cowen analyst Tyler Van Buren reiterated a Buy rating on Summit Therapeutics plc (NASDAQ: SMMT).The analyst comments "In its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
